Analysen von Trung Huynh

16.01.20 Novartis Neutral Credit Suisse Group
16.01.20 GSK neutral Credit Suisse Group
16.01.20 AstraZeneca Outperform Credit Suisse Group
16.01.20 Sanofi Outperform Credit Suisse Group
16.01.20 Merck kaufen Credit Suisse Group
17.10.19 Roche Neutral Credit Suisse Group
01.10.19 GSK Neutral Credit Suisse Group
06.09.19 Merck Outperform Credit Suisse Group
08.08.19 Merck Outperform Credit Suisse Group
31.07.19 Bayer Outperform Credit Suisse Group
30.07.19 Sanofi Outperform Credit Suisse Group
26.07.19 AstraZeneca Outperform Credit Suisse Group
26.07.19 Roche Neutral Credit Suisse Group
11.06.19 Novo Nordisk Outperform Credit Suisse Group
28.05.19 Novartis Neutral Credit Suisse Group
17.05.19 Novartis Neutral Credit Suisse Group
15.05.19 Merck Outperform Credit Suisse Group
06.05.19 Novo Nordisk Outperform Credit Suisse Group
29.04.19 Novo Nordisk Outperform Credit Suisse Group
18.04.19 Roche Neutral Credit Suisse Group
30.03.19 AstraZeneca Outperform Credit Suisse Group
08.03.19 Merck Outperform Credit Suisse Group
04.02.19 Novo Nordisk Neutral Credit Suisse Group